Lustich.de does not operate for profit. Surpluses go into charitable projects, for example building schools and wells in Benin (West Africa). Learn more

Gilead Sciences News 2026

News about Gilead Sciences, kept up to date by the Lustich editorial team.

Wetten auf Krebsmedizin: Kalshi bringt Prognosemärkte für FDA-Zulassungen

International·22 July 2026

Betting on Medicine: Kalshi Launches Prediction Markets for FDA Approvals

Kalshi partners with AppliedXL to launch trading contracts for clinical trial outcomes and FDA decisions. Starting July 2026, users can trade on results for major pharmaceutical developments.